NOVEMBER SALE - 20% OFF Everything!Shop Now
Semax Peptide - 10mg / Vial
98.848% HPLC purityLot-tested · COA below

Semax Peptide

$42.00each · 10mg / Vial

4.7· 3 reviewsout of 5In stock

Buy Semax peptide (10 mg vial) for laboratory research. ACTH(4-7)-PGP heptapeptide, 98.85% purity and endotoxin tested, public COA. Ships in 24 hours.

Regular price $52.00Sale price $42.00You save $10.00 (19%)
1

Bundle & Save

Need more?

Select and SubscribeSave 20%
Order within 12h 43m to ship Mon, Nov 23Cutoff 5:00 PM PST · ships next business day
U.S. delivery availableFree shipping on orders over $150.00
Reship policyWrong item sent? We reship it free. Transit issues reviewed case by case.

Secure checkout · Visa · Mastercard · American Express · Discover · PayPal · Venmo · Apple Pay

Test results · tested sample

98.848%

Reported purity · Tested by Janoshik

Tested
Jun 19, 2026
Labeled
10mg / Vial
Lab
Janoshik
View certificate (PDF) →

Product details

Semax, in brief. Semax is a short chain of seven amino acids built from a piece of ACTH, the pituitary hormone that normally tells the adrenal glands to release cortisol. It keeps only the four-residue stretch ACTH(4-7), chosen for its activity in the brain rather than its hormonal role, plus a Pro-Gly-Pro tail to slow its breakdown. In rat brain it raises the growth factor BDNF and activates its receptor, trkB, in the hippocampus, a region central to learning and memory [1]. In rats given an experimental cortical stroke, a week of treatment left the damaged area about 20% smaller and the animals kept a learned avoidance task that untreated rats lost [2,8]. In stroke models it also shifts hundreds of genes tied to inflammation, immunity and nerve signalling [3,5,7]. Semax is a registered drug in Russia but is not approved by the FDA [8]. NextGenPeps supplies Semax as a 10 mg lyophilized research material for laboratory use only.

What does Semax do?

In rat studies it does three main things: it switches on a brain growth-factor system, it limits damage after an experimental stroke, and it reshapes the genes the brain turns on after that injury. All of the work below comes from animal and cell studies, most of it from rats.

  • Growth-factor signalling. A single application raised BDNF protein 1.4-fold and trkB receptor activation 1.6-fold in the rat hippocampus [1].

  • Stroke damage. In a photothrombotic cortical stroke model, treated rats had infarcts about 20% smaller than vehicle-treated rats and did not show the memory deficit seen in controls [2,8].

  • Gene programs after ischemia. In middle cerebral artery occlusion models it damped inflammatory genes and lifted genes related to neurotransmission and immune signalling [3,5,7].

NextGenPeps supplies Semax for in vitro research and approved animal studies only. It is not sold as a drug, supplement or nootropic product.

How does Semax work?

The short answer is that its receptor is not settled, but its downstream effects on BDNF, serotonin turnover and gene expression are well documented in rodents.

Semax is a fragment of ACTH, a melanocortin peptide, but it was designed around the fragment's brain activity rather than its role in the adrenal hormone response. The best characterised readout is the BDNF system. In the rat hippocampus, one application raised BDNF protein 1.4-fold, trkB tyrosine phosphorylation 1.6-fold, and the mRNA for BDNF exon III and for trkB 3-fold and 2-fold [1]. In rodent striatum it raised the serotonin metabolite 5-HIAA by 25% in tissue at 2 hours and to 180% of baseline in extracellular fluid over 1 to 4 hours, without changing dopamine on its own; given before d-amphetamine, it strengthened the amphetamine-induced rise in dopamine and in locomotor activity [4].

After experimental ischemia, Semax works largely through gene expression. In a 90-minute transient occlusion model, RNA sequencing found 394 genes changed more than 1.5-fold at 24 hours in Semax-treated versus saline-treated rats, with inflammatory genes suppressed and neurotransmission genes activated [7]. At the protein level, it cut stress-kinase (pJNK) activation by more than 1.5-fold, raised the pro-survival factor pCREB by more than 1.5-fold in the subcortex, and lowered MMP-9 and c-Fos in the cortex [6]. In a permanent occlusion model the most affected process was the immune response [5].

Diagram of the Semax sequence Met-Glu-His-Phe from ACTH(4-7) plus a Pro-Gly-Pro tail, with three readouts in rat brain: hippocampal BDNF up 1.4-fold and trkB activation up 1.6-fold, striatal 5-HIAA up to 180% of baseline with dopamine unchanged, and inflammatory and immune gene shifts in ischemic cortex.

Figure 1. How Semax is built and what it changes. The ACTH(4-7) head and Pro-Gly-Pro tail, and the main readouts reported in rat hippocampus, striatum and ischemic cortex [1,3,4,5,7]. A simplification; the receptor that starts these effects has not been identified.

What did Semax do in animal studies?

Treated rats had smaller strokes and kept a learned task that untreated rats lost.

In the clearest outcome study, rats received a focal photothrombotic stroke in the prefrontal cortex and were then treated intranasally once a day for a week. The infarcted area was about 20% smaller in Semax-treated rats than in vehicle-treated rats, and while vehicle-treated rats showed a memory retention deficit in a passive avoidance task, Semax-treated rats did not [2,8]. Passive avoidance measures whether an animal remembers to stay out of a compartment where it previously had an unpleasant experience, so it is a simple test of learning and memory.

At the molecular level, the hippocampal BDNF system responded within hours of a single dose (Figure 2) [1], and after artery occlusion, Semax shifted markers of cell stress and survival toward the uninjured state [6,7]. Gene-level studies of the stroke models did not report survival or neurological scores, so the functional evidence rests mainly on the infarct and memory results.

Bar chart. Left: infarct area in rats after photothrombotic stroke, vehicle 100% versus Semax about 80%. Right: fold change versus control in rat hippocampus after one dose: BDNF protein 1.4, trkB activation 1.6, BDNF exon III mRNA 3.0, trkB mRNA 2.0.

Figure 2. What Semax did in rats. Infarct area after a week of treatment, as reported for the Romanova study in the FDA briefing [2,8], and maximal BDNF and trkB changes in the hippocampus after one application [1]. Values come from separate rat studies and are not directly comparable.

Semax vs Selank

Both are seven-residue peptides with the same Pro-Gly-Pro tail, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, but they start from different natural peptides and are studied for different things [10].

  • Parent peptide. Semax: ACTH(4-7), a melanocortin fragment. Selank: tuftsin (Thr-Lys-Pro-Arg), an immune-system peptide [10].

  • Sequence. Semax: Met-Glu-His-Phe-Pro-Gly-Pro. Selank: Thr-Lys-Pro-Arg-Pro-Gly-Pro [10].

  • Molecular weight. Semax: 813.93 g/mol (C37H51N9O10S). Selank: 751.9 g/mol (C33H57N11O9).

  • Main research focus. Semax: BDNF signalling, stroke models and memory tasks [1,2]. Selank: anxiety-like behaviour and GABAergic signalling; in rat frontal cortex it changed 45 of 84 neurotransmission genes at 1 hour [10].

No published study has compared the two peptides head to head in the same model.

What is Semax made of?

Semax is a linear heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). The first four residues are positions 4 to 7 of ACTH; the last three are the tripeptide Pro-Gly-Pro, added to make the peptide more resistant to breakdown. Its molecular formula is C37H51N9O10S and its molecular weight is 813.93 g/mol for the free base. The acetate salt is C39H55N9O12S, 874.0 g/mol [8].

The literature calls it both an ACTH(4-10) analogue and ACTH(4-7)PGP. Both names describe the same molecule: the Pro-Gly-Pro tail replaces the native ACTH residues 8 to 10. The Pro-Gly-Pro tripeptide on its own has been tested as a comparison arm in the stroke studies and produced a different pattern of gene changes from Semax [5].

Semax at a glance

  • Compound: Semax, ACTH(4-7)-Pro-Gly-Pro

  • Class: Synthetic heptapeptide; melanocortin (ACTH) fragment analogue

  • Sequence: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)

  • Molecular formula: C37H51N9O10S (free base)

  • Molecular weight: 813.93 g/mol

  • Strength: 10 mg per vial

  • Identity and purity: 98.85% purity with identity by UHPLC-MS on the current lot (independent lab, June 19, 2026); certificate published in the COA library

  • Endotoxin: Under 1 EU per vial on the current lot

  • Appearance: Lyophilized powder, sealed vial

  • Reconstitution: Sterile or bacteriostatic water

  • Half-life: Not established. Semax is quickly hydrolyzed in rat blood and brain tissue, and no clinical pharmacokinetic studies were identified by the FDA [8]

  • Regulatory status: Registered drug in Russia (0.1% and 1% nasal drops); not FDA approved [8]

Is Semax legal or FDA approved?

Semax is not an FDA-approved drug. It is registered in Russia, where it is available as 0.1% and 1% nasal drops [8].

At its July 23 and 24, 2026 meeting, the FDA's Pharmacy Compounding Advisory Committee reviewed Semax for the list of bulk substances that may be used in pharmacy compounding. The FDA's own briefing concluded that the evaluation criteria weighed against listing it, citing thin clinical data and gaps in toxicology [8]. The committee nevertheless voted 8 to 5 in favour [9]. The vote is not binding, and the FDA must still complete rulemaking before anything changes. None of this affects its status as a research material.

What is Semax used to study?

Researchers use Semax mainly as a tool to drive the BDNF system and to study protection after brain ischemia.

  • Ischemic stroke models. Infarct size, memory after cortical stroke, and protein markers of cell stress and survival after artery occlusion [2,6].

  • Neurotrophin signalling. BDNF and trkB expression and activation in the hippocampus [1].

  • Transcriptomics of brain injury. Genome-wide changes in immune, vascular and neurotransmission genes after occlusion [3,5,7].

  • Monoamine systems. Serotonin turnover and amphetamine-induced dopamine release in the striatum [4].

Buying Semax for research: what each vial includes

Every lot is tested by independent labs and the certificate of analysis is published in the NextGenPeps COA library. The current lot was analysed on June 19, 2026 by UHPLC-MS, with 98.85% purity, and endotoxin came in under 1 EU per vial.

  • Verified identity, purity and endotoxin. 98.85% purity and under 1 EU per vial endotoxin on the current lot; the certificate is published in the COA library.

  • US-based fulfilment. Orders ship within 24 hours from the United States, with free US shipping on orders over $150.

  • Research use only. Semax is sold strictly for in vitro and approved animal research. It is not for human or veterinary use and is not sold as a drug, supplement or nootropic.

Semax handling, storage and analytical notes

Format. Supplied as 10 mg lyophilized powder in a sealed vial and reconstituted with sterile or bacteriostatic water. No dosing instructions are supplied, and none should be taken from the studies above.

Storage. Keep the sealed vial at 2 to 8 °C, or -20 °C for longer holding, protected from light. After reconstitution, hold the solution at 2 to 8 °C and avoid repeated freeze-thaw cycles.

Stability in biological samples. Semax is broken down quickly by peptidases in rat blood and brain tissue [8]. Studies measuring it in tissue should process samples promptly and state how breakdown was controlled.

Free base and salt. Semax is handled both as the free base (813.93 g/mol) and as the acetate salt (874.0 g/mol). Molar calculations should use the form on the certificate of analysis.

Naming. Semax is distinct from N-acetyl Semax amidate, a modified analogue with capped ends, and from Selank, which shares only the Pro-Gly-Pro tail.

What is not established about Semax

  • Its receptor. The receptor or binding site that starts Semax's effects has not been identified.

  • Functional recovery in occlusion models. The artery occlusion studies report gene and protein changes, not long-term survival or neurological scores [5,6,7].

  • Independent replication. Most published Semax work comes from a small group of Russian laboratories, and much of the older literature is in Russian.

  • Pharmacokinetics. No half-life has been established, and the FDA identified no clinical pharmacokinetic studies [8].


Research Use Only. The statements made within this website have not been evaluated by the US Food and Drug Administration. These materials are not intended to diagnose, treat, cure or prevent any disease and are not intended for human or veterinary use. Studies described on this page are reported for scientific context and are not guidance of any kind.

Published research

Compound information

Molecular class
Synthetic heptapeptide; ACTH(4-7) melanocortin fragment analogue
Sequence
Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
Molecular formula
C₃₇H₅₁N₉O₁₀S (free base); C₃₉H₅₅N₉O₁₂S (acetate)
Molecular weight
813.93 g/mol (free base); 874.0 g/mol (acetate)
CAS number
80714-61-0
Strength
10 mg per vial
Physical form
Lyophilized powder, sealed vial
Purity
98.85% by UHPLC-MS on the current lot (independent lab, Jun 19, 2026)
Endotoxin
Under 1 EU per vial (current lot)
Structure
Linear peptide; no experimental 3D structure deposited
Regulatory status
Research use only. Registered drug in Russia; not FDA approved

Storage & stability

  • Lyophilized powder
  • Store cold, protected from light
  • Avoid repeated freeze-thaw
  • Rapidly hydrolyzed in biological samples; process tissue promptly
Lyophilized
2 to 8 °C, or -20 °C for longer holding, in the sealed vial
Reconstituted
2 to 8 °C, protected from light
Reconstitute with
Sterile or bacteriostatic water
Molar calculations
Use the form (free base or acetate) on the certificate of analysis

Cited literature

  1. 01
    Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus

    Dolotov OV, Karpenko EA, Inozemtseva LS, et al. · Brain Res 2006 · PubMed · DOI

    A single application raised hippocampal BDNF protein 1.4-fold, trkB phosphorylation 1.6-fold, and BDNF exon III and trkB mRNA 3-fold and 2-fold. Healthy rats; short time course.

  2. 02
    Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex

    Romanova GA, Silachev DN, Shakova FM, et al. · Bull Exp Biol Med 2006 · PubMed · DOI

    Intranasal Semax after photothrombotic prefrontal stroke reduced cortical infarct volume and preserved passive avoidance memory in rats. Short report; the 20% figure comes from the FDA summary of this study.

  3. 03
    The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis

    Medvedeva EV, Dmitrieva VG, Povarova OV, et al. · BMC Genomics 2014 · PubMed · DOI · Free full text

    Microarray study after permanent artery occlusion: Semax changed genes related to immune and vascular systems. Transcript-level data from a single occlusion model.

  4. 04
    Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents

    Eremin KO, Kudrin VS, Saransaari P, et al. · Neurochem Res 2005 · PubMed · DOI

    Striatal 5-HIAA rose 25% in tissue and to 180% of baseline extracellularly; dopamine unchanged alone but amphetamine response enhanced. Single-region microdialysis.

  5. 05
    Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats

    Medvedeva EV, Dmitrieva VG, Limborska SA, Myasoedov NF, Dergunova LV · Mol Genet Genomics 2017 · PubMed · DOI

    In ischemic rat cortex the immune response was the process Semax affected most, while Pro-Gly-Pro alone dampened immune activity. Bioinformatic inference from transcript data.

  6. 06
    Brain protein expression profile confirms the protective effect of the ACTH(4-7)PGP peptide (Semax) in a rat model of cerebral ischemia-reperfusion

    Sudarkina OY, Filippenkov IB, Stavchansky VV, et al. · Int J Mol Sci 2021 · PubMed · DOI · Free full text

    After 90-minute occlusion, Semax cut pJNK by more than 1.5-fold, raised subcortical pCREB by more than 1.5-fold and lowered cortical MMP-9 and c-Fos. Small groups (n=4 to 7), 24 hours only.

  7. 07
    Novel insights into the protective properties of ACTH(4-7)PGP (Semax) peptide at the transcriptome level following cerebral ischaemia-reperfusion in rats

    Filippenkov IB, Stavchansky VV, Denisova AE, et al. · Genes 2020 · DOI

    RNA-Seq found 394 genes changed more than 1.5-fold at 24 hours versus saline, with inflammatory genes suppressed and neurotransmission genes activated. No behavioural outcomes.

  8. 08
    FDA briefing document: Semax and semax acetate, Pharmacy Compounding Advisory Committee

    US Food and Drug Administration · FDA 2026 · Free full text

    Reviews chemistry, nonclinical and clinical data; records Russian registration, about 20% smaller infarcts in the Romanova study, rapid hydrolysis in rat tissue and no clinical pharmacokinetic studies. Concluded the criteria weighed against listing.

  9. 09
    FDA advisory committee backs two more peptides, rejects one for compounding list

    Regulatory Affairs Professionals Society · RAPS, July 2026

    Reports the committee's 8 to 5 vote to recommend Semax for the 503A bulks list. News report of a non-binding vote.

  10. 10
    Selank administration affects the expression of some genes involved in GABAergic neurotransmission

    Volkova A, Shadrina M, Kolomin T, et al. · Front Pharmacol 2016 · DOI

    Selank, a tuftsin analogue with the same Pro-Gly-Pro tail, changed 45 of 84 neurotransmission genes in rat frontal cortex at 1 hour. Comparator reference; Semax not tested.

Frequently asked questions

How is Semax packaged?

Semax is supplied in the product format and quantity shown for the selected variant. Please inspect the sealed package when it arrives and contact support promptly if the package or labeling appears damaged.

How is Semax shipped?

Orders are shipped within the United States via USPS. Transit times are typically 3–7 business days, depending on destination and carrier conditions. Tracking information is provided when available.

How should Semax be stored?

Storage requirements are product-specific. Keep Semax in its original labeled container and follow the product documentation or manufacturer instructions supplied with the order. Contact support if the applicable storage guidance is not available.

What is the refund policy for Semax?

Due to the nature of research materials, NextGenPeps orders are final and are not eligible for refunds, returns, or exchanges. Review the shipping and reship policies before ordering.

Is Semax intended for human use?

No. NextGenPeps materials are supplied strictly for laboratory research and development use and are not intended for human or animal consumption, clinical use, diagnostic use, cosmetic use, or dietary use.

Customer reviews

4.7out of 5 · 3 reviews

Good deals

Great value for Semax. Grabbed a few while it was on sale

Max O.

5 Star Service

My order got lost in transit, and the support team made it right and sent a replacement. Since then Ive received every order with no problems.

Dakota H.

Top quality

No degradation or contaminants. The vial is true to the COA which made reconstituting simple.

Xavier P.

Common research questions

What is Semax?

Semax is a synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, built from the ACTH(4-7) fragment of adrenocorticotropic hormone plus a Pro-Gly-Pro tail that slows its breakdown. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and is a registered drug in Russia, but it is not approved by the FDA. In research it is used mainly to study BDNF signalling and protection after experimental brain ischemia in rats.

What does Semax do?

In rat studies Semax raised BDNF protein 1.4-fold and trkB receptor activation 1.6-fold in the hippocampus after a single application. After an experimental cortical stroke, treated rats had infarcts about 20% smaller than controls and kept a learned avoidance task that controls lost. In artery occlusion models it shifted hundreds of genes toward lower inflammation and higher neurotransmission. These are animal findings and do not establish any effect outside the laboratory.

How does Semax work?

The receptor that starts Semax's effects has not been identified. Its best documented actions are on the BDNF and trkB system in the hippocampus and on serotonin turnover in the striatum, where it raised the metabolite 5-HIAA to 180% of baseline without changing dopamine on its own. After ischemia it works largely through gene expression, damping inflammatory and stress-kinase signals and raising the pro-survival factor pCREB.

What is the difference between Semax and Selank?

Both are seven-residue peptides with the same Pro-Gly-Pro tail and come from the same Russian institute. Semax is built from ACTH(4-7), a melanocortin fragment, and is studied mainly for BDNF signalling and stroke models. Selank is built from tuftsin, an immune peptide, and is studied mainly for anxiety-like behaviour and GABAergic gene expression. No study has compared them head to head.

Is Semax FDA approved?

No. Semax is registered in Russia as nasal drops but is not an FDA-approved drug. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 5 to recommend it for the compounding bulks list, against the FDA staff's own assessment, but the vote is not binding and rulemaking has not been completed. NextGenPeps supplies it for research use only.

What is the half-life of Semax?

A half-life has not been established. Semax is hydrolyzed quickly by peptidases in rat blood and brain tissue, and the FDA's 2026 review found no clinical pharmacokinetic studies. The Pro-Gly-Pro tail was added to slow breakdown compared with the native ACTH fragment, but published data do not give a reliable figure.

Frequently Researched with

GLP-RT

✓ 99.72% purity

GLP-RT

$89.00$71.00

GHK-Cu

✓ 99.73% purity

GHK-Cu

$74.00$59.00

GLOW

✓ 99.71% purity

GLOW

$134.00$107.00

NAD+

✓ 99.81% purity

NAD+

$98.00$78.00

You have an unfinished subscription checkout

Continue your saved checkout, or replace its item with . Your saved selection and existing subscriptions will stay unchanged.

Continue saved checkout
NextGenPeps

Reliable and innovative research with our top-grade research materials and novel research compounds tailored to lead the competitive research industry. Choose research quality. Choose NextGenPeps.

Customer Service: +1 (971) 300-1435

Get 10% Off Your First Order

Sign up now and receive a 10% discount code valid on your next purchase!

Nextgenpeps LLC

The statements made within this website have not been evaluated by the US Food and Drug Administration. The materials offered by this company are not intended to diagnose, treat, cure, or prevent any disease. All research materials on this site are for laboratory research and development use only, and are not intended for human use.

NextGenPeps is a chemical supplier. NextGenPeps is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. NextGenPeps is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

Privacy PolicyTerms & ConditionsAffiliate Program

501 W Broadway Ste A, San Diego, CA 92101

© 2026 NextGenPeps. All rights reserved.

Visa
American Express
Mastercard
PayPal
Discover
Apple Pay